Clinical trial
Hypertonic Saline-hetastarch in Cardiac Surgery
NCT00469716 · Haukeland University Hospital, Other · Completed
Key facts
| NCT number | NCT00469716 |
|---|---|
| Title | Hypertonic Saline-hetastarch in Cardiac Surgery |
| Official title | Infusion of Hypertonic Saline-hetastarch in Cardiac Surgery |
| Acronym | HH |
| Lead sponsor | Haukeland University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Postoperative Cardiorespiratory Failure |
| Intervention type | Drug |
| Interventions | Hypertonic saline (7.2%) hetastarch (6 %)(200/0.5) |
| Enrollment | 50 |
| Start date | Apr 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | May 4, 2007 |
| Last update posted | Aug 24, 2016 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: